| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/18/2001 | US6290951 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells |
| 09/18/2001 | US6290948 Using certain chemokines or biologically active fragments thereof alone or in conjunction with an anti-infective agent or hematopoietic maturing agent. |
| 09/18/2001 | US6290946 Administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. |
| 09/18/2001 | CA2735316A1 Thrombin preparations and process for their production |
| 09/18/2001 | CA2238879C Thereapeutic applications for the anti-t-bam (cd40-l) monoclonal antibody 5c8 |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/18/2001 | CA2079802C Walk-through mutagenesis |
| 09/18/2001 | CA2036197C Modified hil-6 |
| 09/18/2001 | CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor |
| 09/18/2001 | CA1341292C The manufacture and expression of consensus human leukocyte interferon |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/14/2001 | CA2340549A1 Use of a methoxysalicylaldehyde derivative for stabilizing a solid-state protein |
| 09/13/2001 | WO2001067100A1 Bax degradation involvement in tumor survival and progression |
| 09/13/2001 | WO2001067072A1 Gas sensor |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066776A2 Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products |
| 09/13/2001 | WO2001066773A2 Nucleic acids that code for oxidosqualene cyclases |
| 09/13/2001 | WO2001066772A2 Heparinase iii and uses thereof |
| 09/13/2001 | WO2001066771A2 Human serine protease |
| 09/13/2001 | WO2001066770A1 Novel polypeptide--- a human signal peptidase 15 and polynucleotide encoding it |
| 09/13/2001 | WO2001066766A2 A matrix metalloproteinase (mmp-25) expressed in skin cell |
| 09/13/2001 | WO2001066765A2 26583, a serine/threonine phosphatase and uses thereof |
| 09/13/2001 | WO2001066764A2 16835, a human phospholipase c and uses thereof |
| 09/13/2001 | WO2001066763A2 23436, a human ubiquitin protease family member and uses thereof |
| 09/13/2001 | WO2001066759A2 26886, a novel carnitine acyltransferase family member and uses therefor |
| 09/13/2001 | WO2001066758A2 25934, a novel fatty acid desaturase and uses therefor |
| 09/13/2001 | WO2001066757A2 25934, a novel fatty acid desaturase and uses therefor |
| 09/13/2001 | WO2001066749A2 A member of the lectin superfamily |
| 09/13/2001 | WO2001066748A2 Full length expressed human polynucleotides and the polypeptides they encode |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066741A2 Kcnb: a novel potassium channel protein |
| 09/13/2001 | WO2001066738A2 Nucleic acids, encoding human crsp1 and uses thereof |
| 09/13/2001 | WO2001066737A1 Polypeptide inducing apoptosis |
| 09/13/2001 | WO2001066734A1 Polypeptides having activity of stimulating neutrophils |
| 09/13/2001 | WO2001066731A1 A novel polypeptide-human zinc finger protein 32 and the polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066729A1 A novel polypeptide, a human actin 14 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066728A1 A novel polypeptide, a human dna mismatch repair gene protein 11 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066727A1 A novel polypeptide, a human thyrocalcitonin 15 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066726A1 A novel polypeptide, a human excitatory amino acids transporter 17 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066725A1 A novel polypeptide, an external dynein arms dhc1alpha47 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066724A1 A novel polypeptide, a human actin 14 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066721A2 Nucleic acid sensor molecules |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066713A1 Activation of pure prothrombin to thrombin with sodium citrate |
| 09/13/2001 | WO2001066709A2 Sphingomyelinase enzymes and uses relating thereto |
| 09/13/2001 | WO2001066708A2 MATERIALS AND METHODS RELATING TO THE DEGRADATION OF Cdc25A IN RESPONSE TO DNA DAMAGE |
| 09/13/2001 | WO2001066707A1 A novel peptide-human atp-dependent serine proteolytic enzyme 11 and the polynucleotide coding this novel peptide |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066702A1 Cosmetic or pharmaceutical composition useful in inhibiting or delaying human alopecia by means of topical application of the composition |
| 09/13/2001 | WO2001066701A1 A new polypeptide- human nadh dehydrogenase 13 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066597A2 Inflammation-related gene |
| 09/13/2001 | WO2001066596A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066592A1 A novel polypeptide, human rna helicase 9 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066591A1 A novel polypeptide - human receptor-related protein tyrosine phosphatase 11 and a polynucleotide sequence encoding the same |
| 09/13/2001 | WO2001066589A1 A novel polypeptide, beta transductin 11 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066588A1 A novel polypeptide, human interleukin binding factor 1-12 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066586A1 A novel polypeptide, human rna helicase 13 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066585A1 A new polypeptide-human protease regulatory protein 10 and the p olynucleotide encoding it |
| 09/13/2001 | WO2001066584A1 A novel polypeptide, human pax protein 9 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066583A1 A new polypeptide - human zinc finger protein 14 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066582A1 A NEW POLYPEPTIDE-HUMAN ZINC FINGER PROTEIN 27 AND THE POLYNUCLEOTIDE ENCODING It |
| 09/13/2001 | WO2001066581A1 A novel polypeptide, human ribosomal protein s4-19 and the polynucleotide encoding thereof |
| 09/13/2001 | WO2001066580A1 A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066579A1 A new polypeptide- human cytochrome constitutive protein 14 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066577A1 A novel polypeptide - homo signal transduction protein kinase 17 and polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066576A1 A novel polypeptide-homo amyloid 11 and polynucleotide encoding said polypeptide |
| 09/13/2001 | WO2001066575A1 A novel polypeptide, an actin 49 and the polynucleotide encoding the polypeptide |
| 09/13/2001 | WO2001066574A2 Cryptococcal mannoproteins or equivalents thereof for use in modulating neutrophil migration |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066564A2 Gamma-secretase inhibitors |
| 09/13/2001 | WO2001066559A1 INHIBITION OF Tp12 TO TREAT INFLAMMATORY DISEASES |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066164A1 Modified protein matrices |
| 09/13/2001 | WO2001066151A1 Methods and kits for locally administering an active agent to an interstitial space of a host |
| 09/13/2001 | WO2001066149A2 Nucleic acid formulations for gene delivery and methods of use |
| 09/13/2001 | WO2001066147A2 Antimicrobial compounds and formulations |
| 09/13/2001 | WO2001066144A2 Antineoplastic combination comprising an inhibitor of angiogenesis and an inhibitor of dna topoisomerase i enzyme activity |
| 09/13/2001 | WO2001066140A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | WO2001066135A1 Lowering serum lipids |
| 09/13/2001 | WO2001066134A1 Rfrp-containing prolactin secretion regulatory agent |
| 09/13/2001 | WO2001066133A1 Leptin-resistance ameliorating agents |
| 09/13/2001 | WO2001066132A2 Hiv immune adjuvant therapy |
| 09/13/2001 | WO2001066131A1 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase |
| 09/13/2001 | WO2001066130A1 Product and method for biological anchoring of connective tissue to bone |
| 09/13/2001 | WO2001066129A1 Substances for the treatment of spinal muscular atrophy |
| 09/13/2001 | WO2001066128A1 Methods of regulating cytokine signalling |
| 09/13/2001 | WO2001066127A1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 09/13/2001 | WO2001066125A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 09/13/2001 | WO2001066120A1 Nerve growth assistance improvement |
| 09/13/2001 | WO2001066116A1 Method for modulating tumor growth and metastasis of tumor cells |
| 09/13/2001 | WO2001066108A1 Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation |
| 09/13/2001 | WO2001066085A2 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 09/13/2001 | WO2001066080A1 Methods using phytol to improve the appearance of skin and compositions for such methods |
| 09/13/2001 | WO2001066063A2 Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis |